OncoSec Medical Inc ONCSQ

Healthcare Biotechnology

OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method that enables transient expression of recombinant therapeutic molecules in cells. The OMS EP Device is designed to promote cellular uptake of plasmid DNA injected directly into solid tumors to allow subsequent expression of the encoded therapeutic protein. The OMS EP Device can be adapted to treat different tumor types and consists of an electrical pulse generator and a disposable applicator. Its lead product candidate, tavokinogene telseplasmid (TAVO), is a plasmid encoding human interleukin-12.

GREY:ONCSQ - Post by User

OncoSec Medical Inc

Bullboard Posts

Post by Pennystockformulaon Jun 02, 2014 6:18pm

431 Views

Post# 22622793

ONCS making small gains but doesn't look good

I saw this as maybe time to break the March high but ended with an ugly candle. It was up 5% at one point so my signals are good. https://pennystockformula.com/cms/blog/

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale